地高辛过量

Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006;113:2556-2564.

• 摘要

Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976;294:797-800.

• 摘要

Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982;307:1357-1362.

• 摘要

Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6:153-162.

• 摘要

Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31:261-273.

• 摘要

1.  Withering W. An account of the foxglove, and some of its medical uses: with practical remarks on dropsy and other diseases. Birmingham: Swinney for Robinson; 1785.

2.  Yang EH, Shah S, Criley JM. Digitalis toxicity: a fading but crucial complication to recognize. Am J Med. 2012;125:337-343.

• 摘要

3.  Aarnoudse AL, Dieleman JP, Stricker BH. Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Saf. 2007;30:431-436.

• 摘要

4.  Mowry JB, Spyker DA, Cantilena Jr LR, et al. 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol (Phila). 2014;52:1032-1283.

• 摘要

5.  Ordog GJ, Benaron S, Bhasin V, et al. Serum digoxin levels and mortality in 5100 patients. Ann Emerg Med. 1987;16:32-39.

• 摘要

6.  Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68:1667-1676.

• 摘要

7.  Miura T, Kojima R, Sugiura Y, et al. Effect of aging on the incidence of digoxin toxicity Ann Pharmacother. 2000;34:427-432.

• 摘要

8.  Bizjak ED, Mauro VF. Digoxin-macrolide drug interaction. Ann Pharmacother. 1997;31:1077-1079.

• 摘要

9.  De Lannoy IA, Koren G, Klein J, et al. Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. Am J Physiol. 1992;263:F613-F622.

• 摘要

10.  Hanratty CG, McGlinchey P, Johnston GD, et al. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging. 2000;17:353-362.

• 摘要

11.  Fenster PE, White NW Jr, Hanson CD. Pharmacokinetic evaluation of the digoxin-amiodarone interaction. J Am Coll Cardiol. 1985;5:108-112.

• 摘要

12.  Moysey JO, Jaggarao NS, Grundy EN, et al. Amiodarone increases plasma digoxin concentrations. Br Med J 1981;282:272.

• 全文
• 摘要

13.  Pedersen KE, Dorph-Pedersen A, Hvidt S, et al. Digoxin-verapamil interaction. Clin Pharmacol Ther. 1981;30:311-316.

• 摘要

14.  Schenck-Gustafsson K, Dahlqvist R. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction. Br J Clin Pharmacol. 1981;11:181-186.

• 摘要

15.  Waldorff S, Hansen PB, Egeblad H, et al. Interactions between digoxin and potassium-sparing diuretics. Clin Pharmacol Ther. 1983;33:418-423.

• 摘要

16.  Colt HG, Shapiro AP: Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc. 1989;37:323-326.

• 摘要

17.  Steiness E. Digoxin toxicity compared with myocardial digoxin and potassium concentration. Br J Pharmacol. 1978;63:233-237.

• 全文
• 摘要

18.  Kim RB, Wandel C, Leake B, et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res. 1999;16:408-414.

• 摘要

19.  Rosen MR, Wit AL, Hoffman BF. Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis. Am Heart J. 1975;89391-399.

• 摘要

20.  Mandreperla SA, Johnson MA, Nakatani K. Electrophysiologic and electroretinographic evidence for photoreceptor dysfunction as a toxic effect of digoxin. Arch Ophthalmol. 1994;112:807-812.

• 摘要

21.  Wofford JL, Hickey AR, Ettinger WH, et al. Lack of age-related differences in the clinical presentation of digoxin toxicity. Arch Intern Med. 1992;152:2261-2264.

• 摘要

22.  Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006;113:2556-2564.

• 摘要

23.  Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871-878.

• 摘要

24.  Baugher BW, Berman M, Dierksen JE, et al. Digoxin immunoassays on the ARCHITECT i2000SR and ARCHITECT c8000 analyzers are free from interferences of Asian, Siberian, and American Ginseng. J Clin Lab Anal. 2015;29:1-4.

• 摘要

25.  Marchlinski FE, Hook BG, Callans DJ, et al. Which cardiac disturbances should be treated with digoxin immune Fab (ovine) antibody? Am J Emerg Med. 1991;9:24-28.

• 摘要

26.  Dart RC, Borron SW, Caravati EM, et al; Antidote Summit Authorship Group. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2009;54:386-394.e1.

• 全文
• 摘要

27.  Chan BS, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol (Phila). 2014;52:824-836.

• 摘要

28.  Antman EM, Wenger TL, Butler VP Jr, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation. 1990;81:1744-1752.

• 摘要

29.  Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976;294:797-800.

• 摘要

30.  Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982;307:1357-1362.

• 摘要

31.  Lemon M, Andrews DJ, Binks AM, et al. Concentrations of free serum digoxin after treatment with antibody fragments. Br Med J (Clin Res Ed). 1987;295:1520-1521.

• 全文
• 摘要

32.  Miller JJ, Straub RW Jr, Valdes R Jr. Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180. Ther Drug Monit. 1996;18:65-72.

• 摘要

33.  Rainey PM. Effects of digoxin immune Fab (ovine) on digoxin immunoassays. Am J Clin Pathol. 1989;92:779-786.

• 摘要

34.  Oubaassine R, Weckering M, Kessler L, et al. Insulin interacts directly with Na(+)/K(+)ATPase and protects from digoxin toxicity. Toxicology. 2012;299:1-9.

• 摘要

35.  de Silva HA, Fonseka MM, Pathmeswaran A, et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003;361:1935-1938.

• 摘要

36.  Boldy DA, Smart V, Vale JA. Multiple doses of charcoal in digoxin poisoning. Lancet. 1985;2:1076-1077.

• 摘要

37.  Ibanez C, Carcas AJ, Frias J, et al. Activated charcoal increases digoxin elimination in patients. Int J Cardiol. 1995;48:27-30.

• 摘要

38.  Sarubbi B, Ducceschi V, D'Andrea A, et al. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion? Can J Cardiol. 1998;14:1267-1273.

• 摘要

39.  Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6:153-162.

• 摘要

40.  Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31:261-273.

• 摘要

41.  Bateman DN. Digoxin-specific antibody fragments: how much and when? Toxicol Rev. 2004;23:135-143.

• 摘要

42.  Helfant RH, Scherlag BJ, Damato AN. Protection from digitalis toxicity with the prophylactic use of diphenylhydantoin sodium. An arrhythmic-inotropic dissociation. Circulation. 1967;36:119-124.

• 摘要

43.  Rumack BH, Wolfe RR, Gilfrich H. Phenytoin (diphenylhydantoin) treatment of massive digoxin overdose. Br Heart J. 1974;36:405-408.

• 全文
• 摘要

44.  Kirkpatrick CH. Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel. Am J Emerg Med. 1991;9(2 Suppl 1):7-10.

• 摘要

45.  Smith TW. Review of clinical experience with digoxin immune Fab (ovine). Am J Emerg Med. 1991;9:1-6.

• 摘要